Autoimmune Diseases in Dermatology: Key Skin Conditions

Autoimmune diseases occur when the immune system produces antibodies that react against self-tissues, leading to inflammation and damage. In dermatology, these disorders primarily manifest on the skin and mucous membranes but may involve other organs. This article reviews key autoimmune conditions affecting the skin, their pathogenesis, clinical features, diagnosis, and management.

What are autoimmune diseases?

Autoimmunity arises when the body’s immune system fails to distinguish self from non-self, resulting in autoantibodies targeting normal tissues. This can cause tissue damage or impaired function. Skin involvement is common due to its accessibility and immune-rich environment. Genetic predisposition (e.g., HLA associations), environmental triggers (infections, drugs), and loss of immune tolerance contribute to these diseases.

Author information

Reviewed by dermatologists specializing in immunodermatology, drawing from peer-reviewed sources and clinical guidelines.

Dermatitis herpetiformis

Dermatitis herpetiformis is an intensely itchy blistering disorder associated with coeliac disease. It predominantly affects elbows, knees, buttocks, and scalp, presenting as grouped vesicles or erosions on erythematous bases. Histology shows subepidermal blisters with neutrophilic infiltrates and papillary IgA deposits. Pathogenesis involves IgA autoantibodies against epidermal transglutaminase, triggered by gluten sensitivity. Diagnosis relies on biopsy with direct immunofluorescence (DIF). Treatment includes dapsone for rapid symptom control and a strict gluten-free diet to induce remission.

Linear IgA bullous dermatosis

This rare subepidermal blistering disease features tense blisters, often in a ‘pearl necklace’ arrangement on trunk and limbs. It can be idiopathic, drug-induced (e.g., vancomycin), or occur in children (chronic bullous disease of childhood). Autoantibodies target BP180 antigen or type VII collagen in the basement membrane. DIF confirms linear IgA deposition. Dapsone is first-line therapy; alternatives include sulfapyridone or immunosuppressants for refractory cases.

Epidermolysis bullosa acquisita

A mechanobullous disorder with fragility blisters on trauma-prone sites (hands, feet, elbows). Inflammatory variants mimic bullous pemphigoid. Pathogenesis involves IgG against type VII collagen, disrupting anchoring fibrils. DIF shows linear IgG/C3 at the dermal-epidermal junction. Treatment is challenging; options include corticosteroids, dapsone, colchicine, or rituximab.

Bullous systemic lupus erythematosus

Rare in SLE patients, featuring subepidermal blisters on sun-exposed areas. DIF reveals IgG/IgA/IgM at basement membrane. It responds well to dapsone alongside SLE management.

Pemphigus

Pemphigus vulgaris

The most common pemphigus, affecting oral mucosa (90% cases) and skin with flaccid blisters rupturing into painful erosions. Nikolsky sign positive. Autoantibodies target desmoglein 3 (mucosa) and desmoglein 1 (skin). DIF shows intercellular IgG deposition. First-line: rituximab + corticosteroids; alternatives include azathioprine, mycophenolate.

Pemphigus foliaceus

Superficial variant with erosions and flaking (crisps) on seborrheic areas, sparing mucosa. Targets desmoglein 1. Endemic forms (fogo selvagem) linked to environmental factors. Managed with lower-dose immunosuppression.

Paraneoplastic pemphigus

Severe, associated with malignancy (lymphoma, SCC). Polymorphous with stomatitis, lichenoid lesions, blisters. Targets multiple plakin proteins and desmogleins. DIF intercellular + basement membrane. Treat underlying tumor; immunosuppression often ineffective.

Bullous pemphigoid

Common in elderly, with tense bullous on urticarial plaques (flexor surfaces, axillae). Pruritus prominent. IgG against BP180/BP230 hemidesmosomal proteins. DIF linear C3/IgG basement membrane. Topical steroids for mild; systemic steroids ± immunosuppressants for extensive. Dupilumab emerging.

Mucous membrane pemphigoid

Cicatrizing gingivitis, desquamative gingivitis, ocular scarring (symblepharon). Targets BP180, laminin 332. DIF linear basement membrane. Immunosuppression to prevent scarring; IVIG for refractory.

Epidermolysis bullosa acquisita (repeated for completeness)

As above.

Lichen planus pemphigoides

Lichenoid papules evolving to blisters. Targets BP180. DIF linear C3. Steroids effective.

Connective tissue diseases

Systemic lupus erythematosus

Cutaneous lupus: acute (butterfly rash), subacute (annular/polycyclic), discoid (scarring plaques). Photosensitive. DIF lupus band. Hydroxychloroquine cornerstone; steroids, belimumab.

Dermatomyositis

Heliotrope rash, Gottron papules, shawl sign, periungual telangiectasia. Muscle involvement. Anti-Mi2, TIF1γ antibodies. IVIG, methotrexate.

Scleroderma

Localized (morphea) or systemic. Skin thickening, Raynaud’s. Anti-centromere, Scl-70. Immunosuppressants, bosentan.

Vitiligo

Autoimmune destruction of melanocytes causing depigmented patches. Non-segmental common. Topical calcineurin inhibitors, phototherapy, JAK inhibitors (ruxolitinib).

Alopecia areata

Patchy non-scarring alopecia. JAK-STAT pathway. Intralesional steroids, topical immunotherapy, baricitinib.

Diagnosis

Clinical suspicion + biopsy (H&E, DIF, IIF). ELISA for specific autoantibodies. Multidisciplinary approach.

Treatment

• First-line: Topical steroids, emollients.
• Systemic: Corticosteroids, immunosuppressants (azathioprine, MMF), biologics (rituximab, dupilumab).
• Specific: Dapsone (DH, IgA), gluten-free (DH), phototherapy.

Frequently Asked Questions (FAQs)

What causes autoimmune skin diseases?

Genetic susceptibility, triggers like infections/drugs, immune dysregulation lead to autoantibody production.

Can autoimmune skin diseases be cured?

No cure, but remission achievable with treatment. Lifestyle management key.

Are they contagious?

No, purely immune-mediated.

When to see a dermatologist?

Persistent rashes, blisters, unexplained pigmentation changes.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb